Meds A-Z
Velagliflozin Proline Monohydrate
Detailed information about Velagliflozin Proline Monohydrate
Pet Owner Quick Guide
Start here: what this medicine is for, what it does, and when it's usually needed.
Usually used for:
Use this medication only when your veterinarian confirms it matches your pet's condition.
What it does:
Use this medication only when your veterinarian confirms it matches your pet's condition.
When it's needed:
Use this medication only when your veterinarian confirms it matches your pet's condition.
Commonly reported reactions:
- (1 reports)
- (1 reports)
- (1 reports)
What to ask your vet today:
- Is this medicine the right fit for my pet’s current symptoms?
- Which warning signs mean I should call back right away?
- How should I handle missed doses or refusal to take the medicine?
Velagliflozin Proline Monohydrate
Drug type: Generic ingredient • Branded profile • FDA branded products available
Species: Both
Manufacturer: Zoetis
Quick Facts
Official label facts first, then secondary summaries. Marketing content is separated below.
No source yet.
Warnings / Contraindications
No contraindication summary is linked yet.
No owner-focused warning rows are linked yet.
Adverse Reactions
Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.
Tap or hover a reaction to see what it means in plain language.
Most Reported Reactions
| Reaction | Cases | Species | Serious cases |
|---|---|---|---|
| 1 | Cat | 0 | |
| 1 | Dog | 0 | |
| 1 | Dog | 0 | |
| 1 | Dog | 0 | |
| 1 | Dog | 0 | |
| 1 | Dog | 0 | |
| 1 | Dog | 0 | |
| 1 | Cat | 0 |
Species coverage: Cat (20) Dog (12)
View detailed reaction table
| Reaction | Species | Seriousness | Frequency | Reports |
|---|---|---|---|---|
| Dog | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Dog | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Dog | Unknown | - | - |
- https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA case USA-USFDACVM-2024-US-018123
Storage & Handling
No storage/handling guidance is linked yet.
Documents
Official label facts are separated from secondary summaries.
Official documents: 3 • Secondary summaries: 0
- Animal Drugs @ FDA search portal · Official label
- FDA CVM Warning Letter (Senvelgo context) · Safety communication
- Senvelgo FOI Summary (FDA) · FOI summary
No source yet.
- https://animaldrugsatfda.fda.gov/adafda/views/#/search · document · Official label
- https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/boehringer-ingelheim-animal-health-usa-inc-695225-01032025 · document · Safety communication
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/14320 · document · FOI summary
Promotional Materials (Marketing)
This content is marketing material and not clinical guidance.
No marketing assets are linked yet.
No source yet.
Technical appendix (vet reference)
Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.
At a Glance
Quick facts and links to official labeling and safety signals.
- Medication catalog: Source PetWisePlus | Refreshed Feb 12, 2026, 10:46 PM UTC
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Feb 16, 2026, 11:00 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Feb 16, 2026, 11:03 AM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Feb 12, 2026, 10:42 PM UTC
Diagnosis-code mappings are not available for this medication yet.
Counseling and Monitoring Highlights
Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.
Enriched Documents
Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.
-
Animal Drugs @ FDA search portal
• Official label • Official
Official FDA veterinary drug portal.
-
FDA CVM Warning Letter (Senvelgo context)
• Safety communication • Official
Official FDA communication referencing Senvelgo and sponsor.
-
Senvelgo FOI Summary (FDA)
• FOI summary • Official
Official FDA Freedom of Information summary for NADA 141-568.
Data Sources & Revision History
Every non-trivial field is expected to include provenance and update timestamps.
- monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-02-16)
- monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-02-15)
- monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-02-14)
- monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-02-13)
- monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-02-12)
- approval_reference: NADA 141-568 (Official, 2026-02-16)
- approval_reference: NADA 141-568 (Official, 2026-02-15)
- approval_reference: NADA 141-568 (Official, 2026-02-14)
- approval_reference: NADA 141-568 (Official, 2026-02-13)
- approval_reference: NADA 141-568 (Official, 2026-02-12)
- brand_names: Senvelgo (Official, 2026-02-16)
- brand_names: Senvelgo (Official, 2026-02-15)
- brand_names: Senvelgo (Official, 2026-02-14)
- brand_names: Senvelgo (Official, 2026-02-13)
- brand_names: Senvelgo (Official, 2026-02-12)
- drug_profile_type: branded (Official, 2026-02-16)
- drug_profile_type: branded (Official, 2026-02-15)
- drug_profile_type: branded (Official, 2026-02-14)
- drug_profile_type: branded (Official, 2026-02-13)
- drug_profile_type: branded (Official, 2026-02-12)
- monitoring updated 2026-02-16 11:11 by curated_loader • Clinical monitoring context for feline diabetes management.
- usage updated 2026-02-16 11:11 by curated_loader • Usage statement from FDA warning letter and approved-product context.
- drug_profile_type updated 2026-02-16 11:11 by curated_loader • FDA source confirms Senvelgo as a branded approved product.
- manufacturer_name updated 2026-02-16 11:11 by curated_loader • FDA warning letter identifies the approved sponsor/manufacturer.
- brand_names updated 2026-02-16 11:11 by curated_loader • FDA warning letter references Senvelgo as the approved animal drug.
- approval_reference updated 2026-02-16 11:11 by curated_loader • Official FDA application reference for Senvelgo.
- monitoring updated 2026-02-15 11:11 by curated_loader • Clinical monitoring context for feline diabetes management.
- usage updated 2026-02-15 11:11 by curated_loader • Usage statement from FDA warning letter and approved-product context.
- drug_profile_type updated 2026-02-15 11:11 by curated_loader • FDA source confirms Senvelgo as a branded approved product.
- manufacturer_name updated 2026-02-15 11:11 by curated_loader • FDA warning letter identifies the approved sponsor/manufacturer.
- brand_names updated 2026-02-15 11:11 by curated_loader • FDA warning letter references Senvelgo as the approved animal drug.
- approval_reference updated 2026-02-15 11:11 by curated_loader • Official FDA application reference for Senvelgo.
- monitoring updated 2026-02-14 11:10 by curated_loader • Clinical monitoring context for feline diabetes management.
- usage updated 2026-02-14 11:10 by curated_loader • Usage statement from FDA warning letter and approved-product context.
- drug_profile_type updated 2026-02-14 11:10 by curated_loader • FDA source confirms Senvelgo as a branded approved product.
- manufacturer_name updated 2026-02-14 11:10 by curated_loader • FDA warning letter identifies the approved sponsor/manufacturer.
- brand_names updated 2026-02-14 11:10 by curated_loader • FDA warning letter references Senvelgo as the approved animal drug.
- approval_reference updated 2026-02-14 11:10 by curated_loader • Official FDA application reference for Senvelgo.
- monitoring updated 2026-02-13 11:11 by curated_loader • Clinical monitoring context for feline diabetes management.
- usage updated 2026-02-13 11:11 by curated_loader • Usage statement from FDA warning letter and approved-product context.
FDA Products & Applications (Animal Drugs @ FDA)
No linked FDA product applications are available for this ingredient yet.
Usage
No approved usage text is linked yet for this ingredient.
- Catalog species: Both
- Safety reports available: 11 openFDA case summaries (view)
Contraindications
No approved contraindication text is linked yet. Review FDA label highlights and openFDA safety reports before making treatment decisions.
Side Effects
No approved side-effect narrative is linked yet.
openFDA reaction signals are available for Dog 14 and Cat 56 (view top reported reactions).
Top Reported Reactions (openFDA)
Aggregated reaction terms from FDA openFDA reports (not verified; does not prove causation).
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Adverse Event Case Summaries (openFDA)
These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.
Cat, Russian, Male, 14 year, 5.307 kilogram • Drug: MSK, Solution, Oral, Dose: 1 Milligram per kilogram, Frequency: 1 per day • Reactions: Ketosis, Lack of efficacy - NOS • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-056188
- Serious AE: No
- Treated For AE: No
- Sex: Male
- Age: 14.00 Year
- Weight: 5.307 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Solution
- Dose: 1 Milligram per kilogram
- Frequency: 1 per day
Cat, Domestic Shorthair, Male, 19 year, 2.989 kilogram • Drug: MSK, Solution, Oral, Dose: 0.99 Milligram per kilogram, Frequency: 24 per hour • Reactions: Lack of efficacy - NOS • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-056152
- Serious AE: No
- Treated For AE: No
- Sex: Male
- Age: 19.00 Year
- Weight: 2.989 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Solution
- Dose: 0.99 Milligram per kilogram
- Frequency: 24 per hour
Cat, Domestic Shorthair, Female, 10 year, 3.992 kilogram • Drug: MSK, Solution, Oral, Dose: 1.01 Milligram per kilogram, Frequency: 24 per hour • Reactions: Ketosis, Lack of efficacy - NOS • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-056172
- Serious AE: No
- Treated For AE: No
- Sex: Female
- Age: 10.00 Year
- Weight: 3.992 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Solution
- Dose: 1.01 Milligram per kilogram
- Frequency: 24 per hour
Cat, Cat (unknown), Unknown • Drug: MSK, Solution, Unknown • Reactions: Vomiting • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-056176
- Serious AE: No
- Treated For AE: No
- Sex: Unknown
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Solution
Cat, Domestic Shorthair, Female, 10 year, 3.629 kilogram • Drug: MSK, Solution, Oral, Dose: 0.99 Milligram per kilogram, Frequency: 24 per hour • Reactions: Diarrhea, Vomiting, Tiredness (lethargy) • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-056191
- Serious AE: No
- Treated For AE: No
- Sex: Female
- Age: 10.00 Year
- Weight: 3.629 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Solution
- Dose: 0.99 Milligram per kilogram
- Frequency: 24 per hour
Cat, Domestic Shorthair, Female, 12 year, 4.354 kilogram • Drug: MSK, Solution, Parenteral, Dose: 1.03 Milligram per kilogram • Reactions: Vomiting, Haematemesis, Leucocytosis NOS, Neutrophilia, Monocytosis • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-056136
- Serious AE: No
- Treated For AE: No
- Sex: Female
- Age: 12.00 Year
- Weight: 4.354 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Parenteral
- Form: Solution
- Dose: 1.03 Milligram per kilogram
Dog, Dog (unknown), Unknown • Drug: MSK, Solution, Unknown • Reactions: Pica NOS • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-052775
- Serious AE: No
- Treated For AE: No
- Sex: Unknown
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Solution
Dog, Alaskan Malamute, Female, 6 year, 41.277 kilogram • Drug: MSK, Solution, Unknown • Reactions: Polyuria, Inappropriate urination, Urinary tract infection • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-017805
- Serious AE: No
- Treated For AE: Yes
- Sex: Female
- Age: 6.00 Year
- Weight: 41.277 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Solution
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Overdose Information
No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.
Storage & Handling
No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.
Share Your Thoughts
Let others know your experience or advice regarding this medication.
This medication has not been reviewed by a veterinarian yet.